Fundraising Fox

AnaptysBio

NASDAQ: ANAB

San Diego, US · Delaware corporation · 3 known investors

anaptysbio.com ↗

AnaptysBio manages the financial collaborations from Jemperli (with GSK) and imsidolimab (with Vanda), operating a virtual model focused on protecting and returning royalty and milestone value to stockholders. It is a publicly traded biotech company running with fewer than ~10 contractors.

Biotechin /anaptysbio

Founders & leadership

RH
Robert HoffmanExecutive Officer
CG
Carol GallagherDirector
ML
Marco LondeiExecutive Officer
JS
John SchmidDirector
NL
Nicholas LydonDirector
HS
Hamza SuriaExecutive Officer, Director
HR
Hollings RentonDirector
JT
James TopperDirector
DF
Daniel FagaPresident, CEO, and Director
CM
Christopher MurphyCFO
TA
Tiba AynechiDirector

Investors · 3

BioBritLa Jolla
Frazier Life SciencesPalo Altovia James N. Topper · board
Norwest Venture PartnersreportedMenlo Park · $10M – $30Mvia Tiba Aynechi · board

Reported raises · per SEC filings

Form D private placements
▶$40.8MraisedJul 2015 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert HoffmanExecutive Officer
  • Carol GallagherDirector
  • Marco LondeiExecutive Officer
  • Tiba AynechiDirector
  • John SchmidDirector
  • Nicholas LydonDirector
  • Hamza SuriaExecutive Officer, Director
  • Hollings RentonDirector
  • James TopperDirector
Offering amount
$40.8M
Amount sold
$40.8M
First sale
Jul 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.